CMR Surgical Raises USD 240M, Achieving a $1bn Valuation for Series C

September 30, 2019

 

CMR Surgical, a medical start-up founded in 2014 in Cambridge in the UK, has raised £195 million to finance its drive forwards to global commercialisation of its Versius surgical robot. This represents Europe’s largest private financing round in the medical technology sector and a vote of confidence in minimal invasive surgery techniques.Minimally invasive surgery can help reduce pain and scarring for patients, effective in cutting recovery times. The Versius robot can fit comfortably into existing operating theatres, is portable and designed to be affordable to general hospitals. It offers dexterity and precision to surgeons by ‘biomimicking’ the human arm with fully wristed instruments. It has freedom of port platform, 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions. Its versatility also means it can be used in a range of minimal access surgical procedures, helping to reduce the number of people who undergo open surgery each year - currently six million a year. Unlike Intuitive Surgical’s da Vinci robot in which the arms attached to a single cart, Versius has a set of independent arms, each with its own base.

 

 

 

Please reload

RoboCap LLP is an Appointed Representative of Sturgeon Ventures LLP who are authorized and regulated by the FCA (FRN:452811)